# AptarGroup Inc. (ATR) — Financial Analysis

**Exchange:** NYSE  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-05-18  
**Tier:** Free primer (step 2 of 19)  
**Sibling pages:** /stocks/ATR/thesis · /stocks/ATR/memo

## Financial Snapshot

---
ticker: ATR
step: 04
generated: 2026-05-13
source: quick-research
---

### AptarGroup Inc. (ATR) — Financial Snapshot

#### Income Statement Summary

| Metric | FY2022 | FY2023 | FY2024 | YoY |
|--------|--------|--------|--------|-----|
| Revenue | $3.33B | $3.49B | $3.58B | +2.7% |
| Gross Margin | ~35% | ~37% | ~38% | +1pp |
| Operating Margin | ~9% | ~11% | ~11% | flat |
| Net Income | ~$200M | ~$240M | ~$315M | +32% |
| EPS (adj. diluted) | ~$3.50 | ~$4.20 | ~$5.50 | +31% |

*TTM (early 2026): Revenue ~$3.78B (+13.5% YoY); gross margin ~38%; operating margin ~11%*

#### Cash Flow & Balance Sheet (FY2024)

| Metric | Value |
|--------|-------|
| Operating Cash Flow | ~$480M |
| Free Cash Flow | ~$368M (+40% vs. FY2023's $263M) |
| Cash & Equivalents | ~$250M |
| Total Debt | ~$1.6B |

#### Key Ratios (approximate)
- P/E: ~21x (fwd) | EV/EBITDA: ~15x | FCF Yield: ~5%
- Revenue Growth (FY2024): +2.7% | FCF Margin: ~10%

#### Growth Profile
AptarGroup has compounded revenue at ~5% annually and earnings faster through margin expansion. FY2024 saw 32% net income growth on modest top-line growth (~3%), driven by mix shift toward higher-margin Pharma (now the largest segment) and operating leverage. The GLP-1 injectable components opportunity is accelerating — injectables grew 24% in Q4 2024. Beauty also surged 24% driven by fragrance dispensing demand. Q1 2026 showed margin compression, and the stock is down 20%+ in 2025.

#### Forward Estimates
- FY2025 adj. EPS: ~$6.00–$6.50 (consensus, subject to revision)
- Analyst avg. price target: ~$170 (+42% upside from ~$120)
- GLP-1 injectables CAGR: ~9%+ through 2028
- Active material science (AMS) solutions: ~10% CAGR, 11% of Pharma revenue

## Deeper Financial Analysis

The fundamental tier ($1.00) adds 8 dimensions not included here:

- Revenue Breakdown — segment revenue, geographic mix, product-line margins
- Financial Trends — QoQ momentum, leading indicators, inflection points
- Balance Sheet — debt structure, dilution risk, working capital dynamics
- Capital Allocation — ROIC, buyback cadence, reinvestment efficiency
- Earnings Analysis — beats/misses, guidance vs actuals, transcript highlights
- Competitive Positioning — market share, pricing power, peer benchmarks
- Industry Context — TAM, sector tailwinds/headwinds, regulatory backdrop

**API endpoint:** GET /api/v1/research/ATR/fundamental

## Navigation

- Overview: /stocks/ATR
- Financials (this page): /stocks/ATR/financials
- Thesis: /stocks/ATR/thesis
- Investment Memo: /stocks/ATR/memo
- Coverage universe: /stocks